miR372 Promotes Progression of Liver Cancer Cells by Upregulating erbB-2 through Enhancement of YB-1

• Príomhchruthaitheoirí: Zhuojia Lin (Údar), Yanan Lu (Údar), Qiuyu Meng (Údar), Chen Wang (Údar), Xiaonan Li (Údar), Yuxin Yang (Údar), Xiaoru Xin (Údar), Qidi Zheng (Údar), Jie Xu (Údar), Xin Gui (Údar), Tianming Li (Údar), Hu Pu (Údar), Wujun Xiong (Údar), Jiao Li (Údar), Song Jia (Údar), Dongdong Lu (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: Elsevier, 2018-06-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

MicroRNAs are known to be involved in carcinogenesis. Recently, microRNA-372 (miR372) has been proven to play a substantial role in several human cancers, but its functions in liver cancer remain unclear. Herein, our results demonstrate that miR372 accelerates growth of liver cancer cells in vitro a...